Maassen JM - Search Results

1

Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studies.

Maassen JM, Dos Santos Sobrín R, Bergstra SA, Goekoop R, Huizinga TWJ, Allaart CF. Maassen JM, et al. Ann Rheum Dis. 2021 Sep;80(9):1124-1129. doi: 10.1136/annrheumdis-2021-220403. Epub 2021 May 28. Ann Rheum Dis. 2021. PMID: 34049858

2

Phenotype and treatment of elderly onset compared with younger onset rheumatoid arthritis patients in international daily practice.

Maassen JM, Bergstra SA, Chopra A, Govind N, Murphy EA, Vega-Morales D, Huizinga TWJ, Allaart CF. Maassen JM, et al. Rheumatology (Oxford). 2021 Oct 2;60(10):4801-4810. doi: 10.1093/rheumatology/keab102. Rheumatology (Oxford). 2021. PMID: 33537769

3

Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort.

Heckert SL, Maassen JM, le Cessie S, Goekoop-Ruiterman YPM, Güler-Yüksel M, Lems W, Huizinga TW, Bergstra SA, Allaart CF. Heckert SL, et al. Among authors: maassen jm. Ann Rheum Dis. 2024 Jan 11;83(2):161-168. doi: 10.1136/ard-2023-224814. Ann Rheum Dis. 2024. PMID: 37979961 Free PMC article.

4

Tapering of disease-modifying antirheumatic drugs: an overview for daily practice.

Maassen JM, van Ouwerkerk L, Allaart CF. Maassen JM, et al. Lancet Rheumatol. 2021 Sep;3(9):e659-e670. doi: 10.1016/S2665-9913(21)00224-1. Lancet Rheumatol. 2021. PMID: 38287612 Review.

5

Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies.

Heckert SL, Maassen JM, Nevins I, Baudoin P, Steup-Beekman GM, Huizinga TWJ, Bergstra SA, Allaart CF. Heckert SL, et al. Among authors: maassen jm. Rheumatology (Oxford). 2024 Apr 1:keae212. doi: 10.1093/rheumatology/keae212. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38561181

6

RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner.

Wezel A, van der Velden D, Maassen JM, Lagraauw HM, de Vries MR, Karper JC, Kuiper J, Bot I, Quax PH. Wezel A, et al. Among authors: maassen jm. Atherosclerosis. 2015 Jan;238(1):132-9. doi: 10.1016/j.atherosclerosis.2014.11.020. Epub 2014 Nov 22. Atherosclerosis. 2015. PMID: 25484103 Free article.

7

Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response.

Wezel A, de Vries MR, Maassen JM, Kip P, Peters EA, Karper JC, Kuiper J, Bot I, Quax PHA. Wezel A, et al. Among authors: maassen jm. Sci Rep. 2016 Apr 7;6:24248. doi: 10.1038/srep24248. Sci Rep. 2016. PMID: 27053419 Free PMC article.

8

Proton-induced production and radiochemical isolation of ⁴⁴Ti from scandium metal targets for ⁴⁴Ti/⁴⁴Sc generator development.

Radchenko V, Engle JW, Medvedev DG, Maassen JM, Naranjo CM, Unc GA, Meyer CAL, Mastren T, Brugh M, Mausner L, Cutler CS, Birnbaum ER, John KD, Nortier FM, Fassbender ME. Radchenko V, et al. Among authors: maassen jm. Nucl Med Biol. 2017 Jul;50:25-32. doi: 10.1016/j.nucmedbio.2017.03.006. Epub 2017 Apr 7. Nucl Med Biol. 2017. PMID: 28432915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters